Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-08-14
Cy3 NHS ester (non-sulfonated) provides an orange fluorescent tag for accessible primary amines on soluble proteins, peptides, and amine-containing oligonucleotides or DNA. It should be used with a compatible organic co-solvent because it is insoluble in water, and it is not the preferred choice for solvent-sensitive biomolecules that require an entirely aqueous labeling workflow.
-
Necrostatin 2 (Nec-2) Experimental Workflow Guide
2026-08-14
Necrostatin 2 (Nec-2) provides a practical way to test necroptosis inhibition in apoptosis-resistant cell models and ischemic stroke research. This workflow also shows how to use Nec-2 as a pathway comparator when studying membrane damage and ferroptosis without confusing distinct forms of regulated cell death.
-
Cy7 NHS Ester: Practical Labeling Guide
2026-08-13
Cy7 NHS ester (A8109) is a water-soluble Sulfo-Cy7 NHS Ester for attaching near-infrared fluorescence to amino groups on proteins and peptides. It is suited to aqueous biomolecule labeling and near-infrared imaging, but it is not the right choice for non-amine conjugation or long-term storage of prepared dye solutions.
-
Sumatriptan as an Anti-Inflammatory Agent
2026-08-13
This systematic review reframes sumatriptan, traditionally used for migraine and cluster headache, as a candidate modulator of inflammatory signaling. By synthesizing 66 studies, it links 5-HT1B/1D receptor activity with changes in cytokines, NF-κB, nitric oxide signaling, caspases, and CGRP across diverse experimental injury models.
-
Cy7 NHS Ester: Practical NIR Labeling Guide
2026-08-12
Cy7 NHS ester is a water-soluble protein labeling dye for coupling near-infrared fluorescence to amino groups on proteins and peptides. It is well suited to aqueous labeling workflows and near-infrared fluorescent imaging, but conjugate performance, biological function, and live-cell or in vivo compatibility must be validated for each biomolecule rather than assumed from dye specifications alone.
-
Septin4, VHL, and HIF-1α in Cardiomyocyte Apoptosis
2026-08-12
The reference study identifies HIF-1α as a previously unrecognized Septin4-interacting protein in hypoxic cardiomyocytes. It shows that Septin4 facilitates VHL-dependent ubiquitination and degradation of HIF-1α, thereby weakening a protective hypoxia response and intensifying apoptosis.
-
Antimycin A4: From Identity to Assay Insight
2026-08-11
Antimycin A4 is an ATP-citrate lyase inhibitor and mitochondrial research compound with two experimentally important activity axes. This assay-first guide explains how chemical identity, substrate competition, respiratory-chain inhibition, and orthogonal controls shape reliable metabolic interpretation.
-
Streptavidin Magnetic Beads for Cell-Death Assays
2026-08-11
Discover how Benzyl-activated Streptavidin Magnetic Beads can strengthen the pre-analytical phase of cell-death research. This article connects annexin-V biology in myocardial ischemia–reperfusion with practical capture, enrichment, controls, and assay-design decisions.
-
Sulfo-Cy3 NHS Ester for Vascular Imaging
2026-08-10
Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for aqueous protein and peptide labeling. This article translates recent AIBP–LRP2 vascular biology into practical assay decisions, from target selection and controls to imaging and conjugate design.
-
BIBR 1532: Telomerase Inhibitor Workflows
2026-08-09
Build reproducible telomerase inhibition studies around BIBR 1532, from dose-response and telomerase activity assay design to apoptosis confirmation. Its non-nucleosidic hTERT mechanism also provides a practical comparator for telomere-attrition and combination-treatment experiments.
-
T7 RNA Polymerase for Mechanistic RNA Assays
2026-08-08
T7 RNA Polymerase enables defined RNA production for mechanistic studies of RNA stability, modification, and cancer biology. This guide connects T7-based assay design with the DDX21–NAT10–ac4C pathway while separating validated evidence from practical workflow recommendations.
-
NSC-23766: A Rac1 Probe for Glucose Uptake
2026-08-07
Explore how NSC-23766, a Rac GTPase inhibitor, can interrogate the lactate–GPR81–FARP1–RAC1–GLUT4 axis beyond conventional cancer research. This article translates recent metabolic findings into practical assay design, controls, and interpretation strategies.
-
Sodium Nitroprusside (B2026): Reliable NO Donor for Vascular
2026-08-07
This article provides an evidence-based guide for using Sodium Nitroprusside (SKU B2026) as a nitric oxide donor in cell viability, proliferation, and cytotoxicity assays. Addressing real laboratory challenges, it demonstrates how reproducible preparation, mechanistic clarity, and vendor reliability make Sodium Nitroprusside from APExBIO a robust choice for vascular research workflows.
-
Molidustat (BAY85-3934): Advancing HIF Stabilization Protoco
2026-08-06
Molidustat (BAY85-3934) is redefining hypoxia-inducible factor stabilization for renal anemia therapy and in vitro oxygen-sensing research. Its selective inhibition of HIF-PH isoforms enables precise, physiologically attuned erythropoietin stimulation, setting it apart from recombinant EPO and other HIF stabilizers.
-
AIBP-LRP2–HDL Axis Regulates CXCR4+ Capillary Expansion in I
2026-08-06
The referenced study uncovers how AIBP-LRP2–mediated HDL uptake limits CXCR4+ stemlike capillary endothelial cell (CEC) expansion and thereby restricts collateral circulation in ischemic tissues. These insights clarify a two-phase mechanism of vascular remodeling and suggest new strategies for therapeutic revascularization in peripheral artery disease.